BACKGROUND: Medication use among pregnant women is common, yet the safety of these medications for the developing fetus/baby is widely understudied. Quantitative Structure-Activity Relationship (QSAR) models can be used to predict the overall and trimester-specific developmental toxicity potential of chemicals, supporting the development of safer medications for pregnant women and regulatory assessment aligned with the 3Rs ( OBJECTIVES: This study aimed to collect and curate a database of compounds classified according to their developmental toxicity potential, use this database to develop and validate QSAR models for predicting prenatal developmental toxicity, and implement models via a user-friendly online platform to support regulatory assessments of drug candidates. METHODS: We compiled and curated data from the FDA and Teratogen Information System (TERIS) databases and validated annotations with rigorous literature searches. The database was leveraged to create QSAR models using machine learning algorithms (RF, SVM, LightGBM) with Bayesian hyperparameter optimization. These models were implemented into a web tool. RESULTS: We built a binary classification QSAR model for overall pregnancy risk, and separate QSAR models for trimester-specific risk, exhibiting correct classification rates of and 76% (overall), 80% (1 CONCLUSIONS: DeTox can be employed to support regulatory assessment of pharmaceutical and cosmetic products aligned with the 3Rs of animal testing and to guide the development of safer drugs for pregnant populations. The curated dataset of developmental toxicants is publicly available, and all models are implemented in a public, user-friendly web tool, DeTox (